We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Regulator Says Limit Trial Size to What Will Prove Safety, Efficacy
UK Regulator Says Limit Trial Size to What Will Prove Safety, Efficacy
Medical devicemakers should avoid recruiting and putting at risk an unnecessarily large number of patients in clinical trials, the UK’s Medicines and Healthcare products Regulatory Agency says in one of five trial-related guidances issued last month.